Literature DB >> 12007187

Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas.

Anju Zhang1, Chengyun Zheng, Mi Hou, Charlotta Lindvall, Keng-Ling Wallin, Tord Angström, Xiaoyan Yang, Ann-Cathrin Hellström, Elisabeth Blennow, Magnus Björkholm, Anders Zetterberg, Astrid Gruber, Dawei Xu.   

Abstract

The expression of telomerase reverse transcriptase (hTERT), the catalytic component of the telomerase complex, is required for activation of telomerase during immortalization and transformation of human cells. However, the biochemical and genetic mechanisms governing hTERT expression remain to be elucidated. In the present study, we examined hTERT amplification as a potential genetic event contributing to telomerase activation in cervical carcinomas. An amplification of the hTERT gene was found in 1/4 cervical cancer cell lines and 21/88 primary tumor samples derived from the patients with cervical carcinomas. An increase in the hTERT copy number was significantly correlated with higher levels of hTERT protein expression. Moreover, the hTERT alterations with the enhanced hTERT expression were exclusively observed in those tumors with high-risk human papillomavirus infection. Taken together, the hTERT gene amplification, directly or indirectly targeted by human papillomavirus, may be one of the driving forces responsible for upregulation of hTERT expression and activation of telomerase in cervical cancers. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007187     DOI: 10.1002/gcc.10071

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  21 in total

Review 1.  Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.

Authors:  Jiyue Zhu; Yuanjun Zhao; Shuwen Wang
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

2.  Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome.

Authors:  Anju Zhang; Chengyun Zheng; Mi Hou; Charlotta Lindvall; Ke-Jun Li; Fredrik Erlandsson; Magnus Björkholm; Astrid Gruber; Elisabeth Blennow; Dawei Xu
Journal:  Am J Hum Genet       Date:  2003-03-10       Impact factor: 11.025

3.  Expression analysis of apolipoprotein E and its associated genes in gastric cancer.

Authors:  Xiumin Shi; Jianting Xu; Jihan Wang; Meizi Cui; Yushun Gao; Haitao Niu; Haofan Jin
Journal:  Oncol Lett       Date:  2015-07-01       Impact factor: 2.967

4.  hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.

Authors:  Xing Fan; Yunyue Wang; John Kratz; Dan J Brat; Yves Robitaille; Albert Moghrabi; Elizabeth J Perlman; Chi V Dang; Peter C Burger; Charles G Eberhart
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

5.  Association between hTERT activation by HPV E6 proteins and oncogenic risk.

Authors:  Koenraad Van Doorslaer; Robert D Burk
Journal:  Virology       Date:  2012-08-25       Impact factor: 3.616

6.  Rearrangement of upstream sequences of the hTERT gene during cellular immortalization.

Authors:  Yuanjun Zhao; Shuwen Wang; Evgenya Y Popova; Sergei A Grigoryev; Jiyue Zhu
Journal:  Genes Chromosomes Cancer       Date:  2009-11       Impact factor: 5.006

Review 7.  Telomeres and telomerase in prostate cancer development and therapy.

Authors:  Mindy Kim Graham; Alan Meeker
Journal:  Nat Rev Urol       Date:  2017-07-04       Impact factor: 14.432

8.  Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Authors:  Judith N Kloth; Jan Oosting; Tom van Wezel; Karoly Szuhai; Jeroen Knijnenburg; Arko Gorter; Gemma G Kenter; Gert Jan Fleuren; Ekaterina S Jordanova
Journal:  BMC Genomics       Date:  2007-02-20       Impact factor: 3.969

9.  Telomere shortening may be associated with human keloids.

Authors:  Bruna De Felice; Robert R Wilson; Massimo Nacca
Journal:  BMC Med Genet       Date:  2009-10-28       Impact factor: 2.103

10.  Azidothymidine "Clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors.

Authors:  Emanuela Berrino; Andrea Angeli; Dmitry D Zhdanov; Anna P Kiryukhina; Andrea Milaneschi; Alessandro De Luca; Murat Bozdag; Simone Carradori; Silvia Selleri; Gianluca Bartolucci; Thomas S Peat; Marta Ferraroni; Claudiu T Supuran; Fabrizio Carta
Journal:  J Med Chem       Date:  2020-06-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.